ATE454629T1 - Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay) - Google Patents

Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)

Info

Publication number
ATE454629T1
ATE454629T1 AT06828568T AT06828568T ATE454629T1 AT E454629 T1 ATE454629 T1 AT E454629T1 AT 06828568 T AT06828568 T AT 06828568T AT 06828568 T AT06828568 T AT 06828568T AT E454629 T1 ATE454629 T1 AT E454629T1
Authority
AT
Austria
Prior art keywords
immunoassay
analyte
antibody
antigen
treatment
Prior art date
Application number
AT06828568T
Other languages
German (de)
English (en)
Inventor
Pavel Strohner
Original Assignee
Pavel Strohner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pavel Strohner filed Critical Pavel Strohner
Application granted granted Critical
Publication of ATE454629T1 publication Critical patent/ATE454629T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06828568T 2005-12-02 2006-11-29 Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay) ATE454629T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005057920A DE102005057920A1 (de) 2005-12-02 2005-12-02 Immunoassay zur simultanen immunchemischen Bestimmung eines Analyten (Antigen) und eines gegen den Analyten gerichteten Therapieantikörpers in Proben
PCT/DE2006/002107 WO2007062628A2 (de) 2005-12-02 2006-11-29 Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)

Publications (1)

Publication Number Publication Date
ATE454629T1 true ATE454629T1 (de) 2010-01-15

Family

ID=37965064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06828568T ATE454629T1 (de) 2005-12-02 2006-11-29 Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)

Country Status (7)

Country Link
US (1) US20080280311A1 (https=)
EP (1) EP1957980B1 (https=)
JP (1) JP4918556B2 (https=)
AT (1) ATE454629T1 (https=)
CA (1) CA2640835C (https=)
DE (2) DE102005057920A1 (https=)
WO (1) WO2007062628A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034714A1 (de) * 2009-07-24 2011-01-27 Biotez Berlin-Buch Gmbh Biochemisch-Technologisches Zentrum Immunoassay zur Bestimmung des freien Targets (Antigen) in Proben, gegen das ein therapeutischer Antikörper gerichtet ist (Free Target Immunoassay)
JP5697677B2 (ja) 2009-10-26 2015-04-08 ネステク ソシエテ アノニム 抗tnf薬及び自己抗体の検出用アッセイ
NZ609363A (en) 2010-10-18 2015-04-24 Nestec Sa Methods for determining anti-drug antibody isotypes
DE102010050140A1 (de) * 2010-11-03 2012-05-03 Biotez Berlin-Buch Gmbh Recovery Immunoassay zur gleichzeitigen immunchemischen Bestimmung eines Analyten (Antigen) und eines gegen den Analyten gerichteten Therapieantikörpers
KR20140047628A (ko) * 2011-07-06 2014-04-22 네스텍 소시에테아노님 Tnf알파로의 생물학적 치료요법에 대한 중화 자가항체의 검출을 위한 검정
US20130266963A1 (en) * 2011-07-06 2013-10-10 Nestec S.A. Assay for detecting neutralizing autoantibodies to biologic therapy
CN107250798A (zh) 2014-12-05 2017-10-13 雀巢产品技术援助有限公司 用于检测患者样品中的生物制品的间接均相迁移率变动试验

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138712A1 (de) * 1991-11-20 1993-05-27 Pavel Dr Strohner Verfahren zur schnelloptimierung und gezielten qualitaetskontrolle von immunoassays aller provenienzen sowie vorrichtung zur durchfuehrung des verfahrens
JPH0772150A (ja) * 1993-09-02 1995-03-17 Tonen Corp IgEの測定方法
DE19532655A1 (de) * 1995-08-24 1997-02-27 Pavel Dr Strohner Verfahren zur zweidimensionalen Bestimmung von Proben in Immunoassays
US5945294A (en) * 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US6127130A (en) * 1998-03-13 2000-10-03 The United States Of America As Represented By The Secretary Of The Navy Multiassay method for determining the concentrations of antigens and interferants
JP2002350447A (ja) * 2001-05-24 2002-12-04 Wako Pure Chem Ind Ltd 生理活性物質固定化担体及びその製造方法、固定化生理活性物質、試料中の対象成分分析方法、並びに試料中の対象成分分析用キット
GB0509512D0 (en) * 2005-05-10 2005-06-15 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1957980A2 (de) 2008-08-20
DE502006005889D1 (de) 2010-02-25
JP2009517667A (ja) 2009-04-30
JP4918556B2 (ja) 2012-04-18
CA2640835C (en) 2014-03-18
CA2640835A1 (en) 2007-06-07
WO2007062628A2 (de) 2007-06-07
DE102005057920A1 (de) 2007-06-28
US20080280311A1 (en) 2008-11-13
EP1957980B1 (de) 2010-01-06
WO2007062628A3 (de) 2007-07-19

Similar Documents

Publication Publication Date Title
EA201070687A1 (ru) Способ ингибирования лейкозных стволовых клеток
DE60130538D1 (de) Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
UA106194C2 (ru) Диагностика и лечение рака с применением антитела к ereg
BRPI0518994A2 (pt) anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
PT1639011E (pt) Anticorpos (dab) de domínio único peguilados
UA109633C2 (uk) Антитіло людини проти тканинного фактора
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
WO2010043977A3 (en) Dengue virus neutralizing antibodies and uses thereof
TW200639181A (en) Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
AR078650A1 (es) Anticuerpo de union a il-1 beta
DK1446157T3 (da) Antistoffer til inhibering af blodkoagulation og fremgangsmåder til anvendelse deraf
ATE441116T1 (de) Verfahren zur selektiven bestimmung von procalcitonin 1-116 für diagnostische zwecke sowie antikírper und kits zur ausführung dieses verfahrens
EA200600905A1 (ru) АНТИГЕНСВЯЗЫВАЮЩИЕ МОЛЕКУЛЫ, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ АФФИННОСТЬЮ К СВЯЗЫВАНИЮ С Fc-РЕЦЕПТОРОМ И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ
WO2006078746A3 (en) Method, compositions and classification for tumor diagnostics and treatment
ATE505544T1 (de) Monoklonale antikörper und einzelkettenantikörper fragments gegen das zelloberflächen prostataspezifische membranantigen
EA030259B8 (ru) Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf
EP2444422A3 (en) Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
WO2006066078A3 (en) Fcϝriib-specific antibodies and methods of use thereof
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
DE602004025101D1 (de) Humane anti-humane cd3-bindungsmoleküle
EP2295465A3 (en) Human monoclonal antibodies to influenza M2 protein and methods of making and using same
UA105760C2 (uk) Антитіло проти bst2
WO2008136774A8 (en) Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
WO2008151819A3 (en) Treatment of tumors using specific anti-l1 antibody